Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 27, 2017

DrugPatentWatch Database Preview

Mitomycin - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for mitomycin and what is the scope of mitomycin freedom to operate?

Mitomycin
is the generic ingredient in four branded drugs marketed by Hospira, West-ward Pharms Int, Bristol Myers, Accord Hlthcare, Bristol, Supergen, and Mobius Therap, and is included in eight NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Mitomycin has eight patent family members in five countries.

There are seven drug master file entries for mitomycin. Three suppliers are listed for this compound.

Summary for Generic Name: mitomycin

Tradenames:4
Patents:4
Applicants:7
NDAs:8
Drug Master File Entries: see list7
Suppliers / Packagers: see list3
Bulk Api Vendors: see list52
Clinical Trials: see list69
Patent Applications: see list9,782
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mitomycin at DailyMed

Pharmacology for Ingredient: mitomycin

Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mobius Therap
MITOSOL
mitomycin
FOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe
West-ward Pharms Int
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064117-002Apr 19, 1995APRXNoNo► Subscribe► Subscribe
Accord Hlthcare
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064144-003Aug 11, 2009APRXNoYes► Subscribe► Subscribe
Accord Hlthcare
MITOMYCIN
mitomycin
INJECTABLE;INJECTION064144-001Apr 30, 1998APRXNoYes► Subscribe► Subscribe
Supergen
MITOZYTREX
mitomycin
INJECTABLE;INJECTION050763-001Nov 14, 2002DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot